MDA Funds 'Omics for Neuromuscular Disease Studies | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – As part of a new $13.7 million funding round, the Muscular Dystrophy Association has awarded grants to several research groups that will use genomics and genetics-based science to investigate the molecular causes of neuromuscular diseases.

The new funding will support a total of 40 researchers studying Duchenne muscular dystrophy (DMD), ALS/Lou Gehrig's disease, muscular atrophy, facioscapulohumeral muscular dystrophy, and links between diabetes and Freidreich's ataxia.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: variant linked to obesity risk in Samoans, health of cloned animals, and more.

Researchers explore using genome editing to treat inherited eye diseases, New Scientist reports.

Olympic athletes this summer will also undergo gene doping testing, according to Wired.

A study finds that the lower funding rate seen among women of color is more due to race than gender, according to BuzzFeed News.